Search The Medical Knowledge Base

Drug Details

ZENAPAX

• Drug Class Description
  Immunosuppressants (interleukin-2 receptor antagonists).
• Generic Name
  Daclizumab
• Presentation
  Infusion, daclizumab 5mg /mL.
• Description
  Concentrate in vial for solution for infusion.
• Indications
  Prophylaxis of acute organ rejection in de novo allogeneic renal transplants in conjunction with an immunosuppressive regimen.
• Adult Dosage
  1mg/kg by intravenous infusion over 15 minutes starting within 24 hours before transplantation. Repeat four times daily at 14 day intervals.
• Child Dosage
  As for adults.
• Contra Indications
  Pregnancy and lactation.
• Special Precautions
  Cardiopulmonary resuscitation equipment must be available.
• Adverse Drug Reactions
  Similar to placebo.